Clinical Study results on the influence
TPI provides its latest research note on MGC Pharmaceuticals Limited (MXC.L).
In anticipation of a sharp ramp-up in operational activities during 2022, MGC has today announced its successful raising of £5.5m (gross) new funding through an equity placing priced at 2p/share
TPI provides its latest research note on MGC Pharmaceuticals Limited (MXC.L).
MGC yesterday received Ethics Committee approval for the Phase III Clinical Trial (‘the Trial’) of CimetrA™ on Patients Diagnosed with COVID-19 (SARS-CoV-2). CimetrA™ is designed with the scientific aim to
Share Talk Bulletin Board Heroes, Thursday 25th February 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Weekend Edition, Bulletin Board Heroes, Sunday 21st February 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 18th February 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Monday 15th February 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 11th February 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
St Brides Partners Weekly Brief, 22nd February 2020
Trains less packed, queues for lunchtime sarnies shorter, fewer people rushing to and from work – welcome to half term week in the City.
St Brides Partners Weekly Brief, 31st January 2020
With January finally drawing to a close, it cannot be said the first month of the year did not go by quietly: the Royal Family drama (worthy of a new
St Brides Partners Weekly Brief
Another week of January has trundled along, but not without note: coronavirus is wreaking havoc, Davos has done the same, and the weather continues to turn in Australia.